nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—S1PR1—umbilical vein—urinary bladder cancer	0.0426	0.132	CbGeAlD
Fingolimod—S1PR5—prostate gland—urinary bladder cancer	0.0169	0.0522	CbGeAlD
Fingolimod—CYP4F2—prostate gland—urinary bladder cancer	0.0158	0.0489	CbGeAlD
Fingolimod—S1PR3—prostate gland—urinary bladder cancer	0.014	0.0434	CbGeAlD
Fingolimod—S1PR1—prostate gland—urinary bladder cancer	0.0123	0.0383	CbGeAlD
Fingolimod—SPHK1—prostate gland—urinary bladder cancer	0.0122	0.0379	CbGeAlD
Fingolimod—CYP4F12—prostate gland—urinary bladder cancer	0.0117	0.0364	CbGeAlD
Fingolimod—CYP4F2—renal system—urinary bladder cancer	0.0108	0.0334	CbGeAlD
Fingolimod—CYP4F12—seminal vesicle—urinary bladder cancer	0.00993	0.0308	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—urinary bladder cancer	0.00992	0.0307	CbGeAlD
Fingolimod—S1PR5—female reproductive system—urinary bladder cancer	0.0092	0.0285	CbGeAlD
Fingolimod—S1PR1—epithelium—urinary bladder cancer	0.00907	0.0281	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—urinary bladder cancer	0.00874	0.0271	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—urinary bladder cancer	0.00865	0.0268	CbGeAlD
Fingolimod—SPHK1—renal system—urinary bladder cancer	0.00833	0.0258	CbGeAlD
Fingolimod—SPHK1—urethra—urinary bladder cancer	0.00818	0.0253	CbGeAlD
Fingolimod—CYP4F12—urethra—urinary bladder cancer	0.00786	0.0243	CbGeAlD
Fingolimod—CYP4F2—vagina—urinary bladder cancer	0.0078	0.0242	CbGeAlD
Fingolimod—S1PR3—female reproductive system—urinary bladder cancer	0.00765	0.0237	CbGeAlD
Fingolimod—S1PR1—female reproductive system—urinary bladder cancer	0.00674	0.0209	CbGeAlD
Fingolimod—SPHK1—female reproductive system—urinary bladder cancer	0.00667	0.0207	CbGeAlD
Fingolimod—CYP4F12—female reproductive system—urinary bladder cancer	0.00641	0.0199	CbGeAlD
Fingolimod—S1PR4—lymph node—urinary bladder cancer	0.0064	0.0198	CbGeAlD
Fingolimod—S1PR1—vagina—urinary bladder cancer	0.0061	0.0189	CbGeAlD
Fingolimod—SPHK1—vagina—urinary bladder cancer	0.00603	0.0187	CbGeAlD
Fingolimod—CYP4F12—vagina—urinary bladder cancer	0.00579	0.018	CbGeAlD
Fingolimod—CYP2E1—urine—urinary bladder cancer	0.00551	0.0171	CbGeAlD
Fingolimod—S1PR5—lymph node—urinary bladder cancer	0.00538	0.0167	CbGeAlD
Fingolimod—S1PR3—lymph node—urinary bladder cancer	0.00447	0.0139	CbGeAlD
Fingolimod—CYP3A4—urine—urinary bladder cancer	0.00444	0.0137	CbGeAlD
Fingolimod—CYP2D6—urine—urinary bladder cancer	0.00437	0.0135	CbGeAlD
Fingolimod—CYP3A4—Thiotepa—urinary bladder cancer	0.00423	0.378	CbGbCtD
Fingolimod—S1PR1—lymph node—urinary bladder cancer	0.00394	0.0122	CbGeAlD
Fingolimod—SPHK1—lymph node—urinary bladder cancer	0.0039	0.0121	CbGeAlD
Fingolimod—CYP2E1—Etoposide—urinary bladder cancer	0.00378	0.339	CbGbCtD
Fingolimod—CYP4F12—lymph node—urinary bladder cancer	0.00375	0.0116	CbGeAlD
Fingolimod—CYP2E1—prostate gland—urinary bladder cancer	0.00198	0.00613	CbGeAlD
Fingolimod—CYP2E1—seminal vesicle—urinary bladder cancer	0.00167	0.00519	CbGeAlD
Fingolimod—CYP2E1—renal system—urinary bladder cancer	0.00135	0.00418	CbGeAlD
Fingolimod—CYP2E1—urethra—urinary bladder cancer	0.00133	0.00411	CbGeAlD
Fingolimod—Dyspnoea—Mitomycin—urinary bladder cancer	0.00128	0.00566	CcSEcCtD
Fingolimod—Cerebrovascular accident—Gemcitabine—urinary bladder cancer	0.00126	0.00558	CcSEcCtD
Fingolimod—Fatigue—Mitomycin—urinary bladder cancer	0.00124	0.00548	CcSEcCtD
Fingolimod—CYP2D6—Doxorubicin—urinary bladder cancer	0.00123	0.11	CbGbCtD
Fingolimod—Cerebrovascular accident—Cisplatin—urinary bladder cancer	0.00118	0.0052	CcSEcCtD
Fingolimod—Herpes zoster—Methotrexate—urinary bladder cancer	0.00116	0.00512	CcSEcCtD
Fingolimod—Cardiac arrest—Fluorouracil—urinary bladder cancer	0.00116	0.00511	CcSEcCtD
Fingolimod—CYP3A4—Etoposide—urinary bladder cancer	0.00115	0.103	CbGbCtD
Fingolimod—Liver function test abnormal—Gemcitabine—urinary bladder cancer	0.00114	0.00505	CcSEcCtD
Fingolimod—Pneumonia—Thiotepa—urinary bladder cancer	0.00114	0.00504	CcSEcCtD
Fingolimod—Infestation—Thiotepa—urinary bladder cancer	0.00113	0.00501	CcSEcCtD
Fingolimod—Infestation NOS—Thiotepa—urinary bladder cancer	0.00113	0.00501	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00111	0.00492	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00109	0.00482	CcSEcCtD
Fingolimod—CYP3A4—renal system—urinary bladder cancer	0.00109	0.00336	CbGeAlD
Fingolimod—Herpes zoster—Epirubicin—urinary bladder cancer	0.00108	0.00479	CcSEcCtD
Fingolimod—CYP2E1—female reproductive system—urinary bladder cancer	0.00108	0.00335	CbGeAlD
Fingolimod—Influenza—Gemcitabine—urinary bladder cancer	0.00107	0.00473	CcSEcCtD
Fingolimod—CYP2D6—renal system—urinary bladder cancer	0.00107	0.00331	CbGeAlD
Fingolimod—Aspartate aminotransferase increased—Cisplatin—urinary bladder cancer	0.00104	0.00459	CcSEcCtD
Fingolimod—Asthenia—Mitomycin—urinary bladder cancer	0.00103	0.00456	CcSEcCtD
Fingolimod—Cardiac arrest—Etoposide—urinary bladder cancer	0.001	0.00444	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—urinary bladder cancer	0.001	0.00443	CcSEcCtD
Fingolimod—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.001	0.00442	CcSEcCtD
Fingolimod—Diarrhoea—Mitomycin—urinary bladder cancer	0.000983	0.00435	CcSEcCtD
Fingolimod—Liver injury—Epirubicin—urinary bladder cancer	0.000969	0.00428	CcSEcCtD
Fingolimod—Pneumonia—Gemcitabine—urinary bladder cancer	0.000959	0.00424	CcSEcCtD
Fingolimod—Eye disorder—Thiotepa—urinary bladder cancer	0.000951	0.0042	CcSEcCtD
Fingolimod—Dizziness—Mitomycin—urinary bladder cancer	0.00095	0.0042	CcSEcCtD
Fingolimod—Cardiac disorder—Thiotepa—urinary bladder cancer	0.000944	0.00417	CcSEcCtD
Fingolimod—Pneumonia—Fluorouracil—urinary bladder cancer	0.000943	0.00417	CcSEcCtD
Fingolimod—Infestation NOS—Fluorouracil—urinary bladder cancer	0.000937	0.00414	CcSEcCtD
Fingolimod—Infestation—Fluorouracil—urinary bladder cancer	0.000937	0.00414	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.000932	0.00412	CcSEcCtD
Fingolimod—Angiopathy—Thiotepa—urinary bladder cancer	0.000923	0.00408	CcSEcCtD
Fingolimod—Hepatic enzyme increased—Methotrexate—urinary bladder cancer	0.000922	0.00407	CcSEcCtD
Fingolimod—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.000917	0.00405	CcSEcCtD
Fingolimod—Headache—Mitomycin—urinary bladder cancer	0.0009	0.00398	CcSEcCtD
Fingolimod—Alopecia—Thiotepa—urinary bladder cancer	0.000899	0.00397	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—urinary bladder cancer	0.000897	0.00396	CcSEcCtD
Fingolimod—Mental disorder—Thiotepa—urinary bladder cancer	0.000891	0.00394	CcSEcCtD
Fingolimod—Sinusitis—Fluorouracil—urinary bladder cancer	0.000879	0.00389	CcSEcCtD
Fingolimod—CYP3A4—female reproductive system—urinary bladder cancer	0.000869	0.00269	CbGeAlD
Fingolimod—Back pain—Thiotepa—urinary bladder cancer	0.000857	0.00379	CcSEcCtD
Fingolimod—CYP2D6—female reproductive system—urinary bladder cancer	0.000855	0.00265	CbGeAlD
Fingolimod—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.000841	0.00372	CcSEcCtD
Fingolimod—Atrioventricular block—Epirubicin—urinary bladder cancer	0.000841	0.00372	CcSEcCtD
Fingolimod—Vision blurred—Thiotepa—urinary bladder cancer	0.000835	0.00369	CcSEcCtD
Fingolimod—Pneumonia—Etoposide—urinary bladder cancer	0.000819	0.00362	CcSEcCtD
Fingolimod—Infestation NOS—Etoposide—urinary bladder cancer	0.000814	0.0036	CcSEcCtD
Fingolimod—Infestation—Etoposide—urinary bladder cancer	0.000814	0.0036	CcSEcCtD
Fingolimod—Bradycardia—Cisplatin—urinary bladder cancer	0.000812	0.00359	CcSEcCtD
Fingolimod—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.000794	0.00351	CcSEcCtD
Fingolimod—Leukopenia—Thiotepa—urinary bladder cancer	0.000793	0.0035	CcSEcCtD
Fingolimod—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.000784	0.00346	CcSEcCtD
Fingolimod—CYP3A4—Doxorubicin—urinary bladder cancer	0.000781	0.07	CbGbCtD
Fingolimod—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.000778	0.00344	CcSEcCtD
Fingolimod—Angiopathy—Gemcitabine—urinary bladder cancer	0.000776	0.00343	CcSEcCtD
Fingolimod—Cough—Thiotepa—urinary bladder cancer	0.000773	0.00342	CcSEcCtD
Fingolimod—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.000771	0.00341	CcSEcCtD
Fingolimod—Hypertension—Thiotepa—urinary bladder cancer	0.000765	0.00338	CcSEcCtD
Fingolimod—Alopecia—Gemcitabine—urinary bladder cancer	0.000756	0.00334	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000749	0.00331	CcSEcCtD
Fingolimod—Eye disorder—Cisplatin—urinary bladder cancer	0.000745	0.00329	CcSEcCtD
Fingolimod—Alopecia—Fluorouracil—urinary bladder cancer	0.000744	0.00329	CcSEcCtD
Fingolimod—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00074	0.00327	CcSEcCtD
Fingolimod—Back pain—Gemcitabine—urinary bladder cancer	0.000721	0.00318	CcSEcCtD
Fingolimod—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.000719	0.00318	CcSEcCtD
Fingolimod—Infection—Thiotepa—urinary bladder cancer	0.000718	0.00317	CcSEcCtD
Fingolimod—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000709	0.00313	CcSEcCtD
Fingolimod—Alopecia—Cisplatin—urinary bladder cancer	0.000705	0.00312	CcSEcCtD
Fingolimod—Skin disorder—Thiotepa—urinary bladder cancer	0.000702	0.0031	CcSEcCtD
Fingolimod—Vision blurred—Fluorouracil—urinary bladder cancer	0.00069	0.00305	CcSEcCtD
Fingolimod—Eye disorder—Etoposide—urinary bladder cancer	0.000683	0.00302	CcSEcCtD
Fingolimod—Cardiac disorder—Etoposide—urinary bladder cancer	0.000678	0.003	CcSEcCtD
Fingolimod—Leukopenia—Gemcitabine—urinary bladder cancer	0.000667	0.00295	CcSEcCtD
Fingolimod—Angiopathy—Etoposide—urinary bladder cancer	0.000663	0.00293	CcSEcCtD
Fingolimod—Eczema—Epirubicin—urinary bladder cancer	0.000659	0.00291	CcSEcCtD
Fingolimod—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000659	0.00291	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—urinary bladder cancer	0.000656	0.0029	CcSEcCtD
Fingolimod—Leukopenia—Fluorouracil—urinary bladder cancer	0.000656	0.0029	CcSEcCtD
Fingolimod—Vision blurred—Cisplatin—urinary bladder cancer	0.000654	0.00289	CcSEcCtD
Fingolimod—Cough—Gemcitabine—urinary bladder cancer	0.00065	0.00287	CcSEcCtD
Fingolimod—Paraesthesia—Thiotepa—urinary bladder cancer	0.000649	0.00287	CcSEcCtD
Fingolimod—Alopecia—Etoposide—urinary bladder cancer	0.000646	0.00285	CcSEcCtD
Fingolimod—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.000646	0.00285	CcSEcCtD
Fingolimod—Hypertension—Gemcitabine—urinary bladder cancer	0.000643	0.00284	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00063	0.00278	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000624	0.00276	CcSEcCtD
Fingolimod—Fatigue—Thiotepa—urinary bladder cancer	0.000623	0.00275	CcSEcCtD
Fingolimod—Leukopenia—Cisplatin—urinary bladder cancer	0.000622	0.00275	CcSEcCtD
Fingolimod—Back pain—Etoposide—urinary bladder cancer	0.000615	0.00272	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—urinary bladder cancer	0.00061	0.00269	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—urinary bladder cancer	0.000607	0.00268	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.000604	0.00267	CcSEcCtD
Fingolimod—Infection—Gemcitabine—urinary bladder cancer	0.000604	0.00267	CcSEcCtD
Fingolimod—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000596	0.00264	CcSEcCtD
Fingolimod—Infection—Fluorouracil—urinary bladder cancer	0.000594	0.00262	CcSEcCtD
Fingolimod—Skin disorder—Gemcitabine—urinary bladder cancer	0.000591	0.00261	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000587	0.00259	CcSEcCtD
Fingolimod—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000586	0.00259	CcSEcCtD
Fingolimod—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.000584	0.00258	CcSEcCtD
Fingolimod—Migraine—Epirubicin—urinary bladder cancer	0.000583	0.00258	CcSEcCtD
Fingolimod—Leukopenia—Etoposide—urinary bladder cancer	0.000569	0.00252	CcSEcCtD
Fingolimod—Hypotension—Gemcitabine—urinary bladder cancer	0.000568	0.00251	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—urinary bladder cancer	0.000563	0.00249	CcSEcCtD
Fingolimod—Infection—Cisplatin—urinary bladder cancer	0.000563	0.00249	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.000559	0.00247	CcSEcCtD
Fingolimod—Hypotension—Fluorouracil—urinary bladder cancer	0.000559	0.00247	CcSEcCtD
Fingolimod—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000556	0.00246	CcSEcCtD
Fingolimod—Cough—Etoposide—urinary bladder cancer	0.000555	0.00245	CcSEcCtD
Fingolimod—Skin disorder—Cisplatin—urinary bladder cancer	0.00055	0.00243	CcSEcCtD
Fingolimod—Hypertension—Etoposide—urinary bladder cancer	0.000549	0.00243	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000547	0.00242	CcSEcCtD
Fingolimod—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000546	0.00241	CcSEcCtD
Fingolimod—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000542	0.0024	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—urinary bladder cancer	0.000539	0.00238	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000538	0.00238	CcSEcCtD
Fingolimod—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000537	0.00237	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000533	0.00236	CcSEcCtD
Fingolimod—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000533	0.00236	CcSEcCtD
Fingolimod—Hypotension—Cisplatin—urinary bladder cancer	0.00053	0.00234	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000525	0.00232	CcSEcCtD
Fingolimod—Fatigue—Gemcitabine—urinary bladder cancer	0.000524	0.00232	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.000522	0.00231	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—urinary bladder cancer	0.000521	0.0023	CcSEcCtD
Fingolimod—Asthenia—Thiotepa—urinary bladder cancer	0.000519	0.00229	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000516	0.00228	CcSEcCtD
Fingolimod—Infection—Etoposide—urinary bladder cancer	0.000516	0.00228	CcSEcCtD
Fingolimod—Influenza—Epirubicin—urinary bladder cancer	0.000512	0.00226	CcSEcCtD
Fingolimod—Pruritus—Thiotepa—urinary bladder cancer	0.000511	0.00226	CcSEcCtD
Fingolimod—Paraesthesia—Cisplatin—urinary bladder cancer	0.000509	0.00225	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000506	0.00224	CcSEcCtD
Fingolimod—Dyspnoea—Cisplatin—urinary bladder cancer	0.000505	0.00223	CcSEcCtD
Fingolimod—Skin disorder—Etoposide—urinary bladder cancer	0.000504	0.00223	CcSEcCtD
Fingolimod—Diarrhoea—Thiotepa—urinary bladder cancer	0.000495	0.00219	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000493	0.00218	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—urinary bladder cancer	0.000492	0.00218	CcSEcCtD
Fingolimod—Pneumonia—Methotrexate—urinary bladder cancer	0.00049	0.00217	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000489	0.00216	CcSEcCtD
Fingolimod—Infestation NOS—Methotrexate—urinary bladder cancer	0.000488	0.00215	CcSEcCtD
Fingolimod—Infestation—Methotrexate—urinary bladder cancer	0.000488	0.00215	CcSEcCtD
Fingolimod—Depression—Methotrexate—urinary bladder cancer	0.000486	0.00215	CcSEcCtD
Fingolimod—Hypotension—Etoposide—urinary bladder cancer	0.000485	0.00214	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000483	0.00214	CcSEcCtD
Fingolimod—Dizziness—Thiotepa—urinary bladder cancer	0.000478	0.00211	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—urinary bladder cancer	0.000474	0.00209	CcSEcCtD
Fingolimod—Paraesthesia—Etoposide—urinary bladder cancer	0.000466	0.00206	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—urinary bladder cancer	0.000463	0.00205	CcSEcCtD
Fingolimod—Dyspnoea—Etoposide—urinary bladder cancer	0.000463	0.00205	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—urinary bladder cancer	0.000459	0.00203	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—urinary bladder cancer	0.000456	0.00202	CcSEcCtD
Fingolimod—Infestation—Epirubicin—urinary bladder cancer	0.000456	0.00202	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—urinary bladder cancer	0.000455	0.00201	CcSEcCtD
Fingolimod—Headache—Thiotepa—urinary bladder cancer	0.000453	0.002	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000448	0.00198	CcSEcCtD
Fingolimod—Fatigue—Etoposide—urinary bladder cancer	0.000448	0.00198	CcSEcCtD
Fingolimod—Asthenia—Gemcitabine—urinary bladder cancer	0.000436	0.00193	CcSEcCtD
Fingolimod—Pruritus—Gemcitabine—urinary bladder cancer	0.00043	0.0019	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—urinary bladder cancer	0.000428	0.00189	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—urinary bladder cancer	0.000428	0.00189	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—urinary bladder cancer	0.000425	0.00188	CcSEcCtD
Fingolimod—Pruritus—Fluorouracil—urinary bladder cancer	0.000423	0.00187	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000422	0.00187	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—urinary bladder cancer	0.000422	0.00187	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—urinary bladder cancer	0.000417	0.00184	CcSEcCtD
Fingolimod—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000416	0.00184	CcSEcCtD
Fingolimod—Eye disorder—Methotrexate—urinary bladder cancer	0.000409	0.00181	CcSEcCtD
Fingolimod—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000409	0.00181	CcSEcCtD
Fingolimod—Asthenia—Cisplatin—urinary bladder cancer	0.000407	0.0018	CcSEcCtD
Fingolimod—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000406	0.0018	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000403	0.00178	CcSEcCtD
Fingolimod—Angiopathy—Methotrexate—urinary bladder cancer	0.000397	0.00176	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—urinary bladder cancer	0.000396	0.00175	CcSEcCtD
Fingolimod—Dizziness—Fluorouracil—urinary bladder cancer	0.000395	0.00175	CcSEcCtD
Fingolimod—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000394	0.00174	CcSEcCtD
Fingolimod—Diarrhoea—Cisplatin—urinary bladder cancer	0.000388	0.00171	CcSEcCtD
Fingolimod—Alopecia—Methotrexate—urinary bladder cancer	0.000387	0.00171	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—urinary bladder cancer	0.000386	0.00171	CcSEcCtD
Fingolimod—Mental disorder—Methotrexate—urinary bladder cancer	0.000383	0.00169	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—urinary bladder cancer	0.000383	0.00169	CcSEcCtD
Fingolimod—Headache—Gemcitabine—urinary bladder cancer	0.000381	0.00168	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00038	0.00168	CcSEcCtD
Fingolimod—Headache—Fluorouracil—urinary bladder cancer	0.000374	0.00166	CcSEcCtD
Fingolimod—Asthenia—Etoposide—urinary bladder cancer	0.000372	0.00165	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000372	0.00165	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—urinary bladder cancer	0.000372	0.00164	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000369	0.00163	CcSEcCtD
Fingolimod—Back pain—Methotrexate—urinary bladder cancer	0.000369	0.00163	CcSEcCtD
Fingolimod—Pruritus—Etoposide—urinary bladder cancer	0.000367	0.00162	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—urinary bladder cancer	0.000362	0.0016	CcSEcCtD
Fingolimod—Vision blurred—Methotrexate—urinary bladder cancer	0.000359	0.00159	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—urinary bladder cancer	0.000359	0.00159	CcSEcCtD
Fingolimod—Diarrhoea—Etoposide—urinary bladder cancer	0.000355	0.00157	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—urinary bladder cancer	0.000354	0.00157	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000352	0.00155	CcSEcCtD
Fingolimod—Back pain—Epirubicin—urinary bladder cancer	0.000345	0.00152	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—urinary bladder cancer	0.000344	0.00152	CcSEcCtD
Fingolimod—Dizziness—Etoposide—urinary bladder cancer	0.000343	0.00152	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000342	0.00151	CcSEcCtD
Fingolimod—Leukopenia—Methotrexate—urinary bladder cancer	0.000341	0.00151	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—urinary bladder cancer	0.000336	0.00149	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—urinary bladder cancer	0.000335	0.00148	CcSEcCtD
Fingolimod—Cough—Methotrexate—urinary bladder cancer	0.000332	0.00147	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—urinary bladder cancer	0.000332	0.00147	CcSEcCtD
Fingolimod—Headache—Etoposide—urinary bladder cancer	0.000325	0.00144	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000322	0.00142	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—urinary bladder cancer	0.000319	0.00141	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—urinary bladder cancer	0.000319	0.00141	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—urinary bladder cancer	0.000315	0.00139	CcSEcCtD
Fingolimod—Cough—Epirubicin—urinary bladder cancer	0.000311	0.00138	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—urinary bladder cancer	0.000311	0.00137	CcSEcCtD
Fingolimod—Infection—Methotrexate—urinary bladder cancer	0.000309	0.00137	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—urinary bladder cancer	0.000308	0.00136	CcSEcCtD
Fingolimod—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000305	0.00135	CcSEcCtD
Fingolimod—Skin disorder—Methotrexate—urinary bladder cancer	0.000302	0.00134	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000301	0.00133	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—urinary bladder cancer	0.000295	0.00131	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—urinary bladder cancer	0.000292	0.00129	CcSEcCtD
Fingolimod—Hypotension—Methotrexate—urinary bladder cancer	0.000291	0.00128	CcSEcCtD
Fingolimod—Infection—Epirubicin—urinary bladder cancer	0.000289	0.00128	CcSEcCtD
Fingolimod—Cough—Doxorubicin—urinary bladder cancer	0.000288	0.00127	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000285	0.00126	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—urinary bladder cancer	0.000285	0.00126	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—urinary bladder cancer	0.000283	0.00125	CcSEcCtD
Fingolimod—Paraesthesia—Methotrexate—urinary bladder cancer	0.000279	0.00123	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000279	0.00123	CcSEcCtD
Fingolimod—Dyspnoea—Methotrexate—urinary bladder cancer	0.000277	0.00123	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—urinary bladder cancer	0.000272	0.0012	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000268	0.00119	CcSEcCtD
Fingolimod—Fatigue—Methotrexate—urinary bladder cancer	0.000268	0.00118	CcSEcCtD
Fingolimod—Infection—Doxorubicin—urinary bladder cancer	0.000268	0.00118	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000264	0.00117	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—urinary bladder cancer	0.000262	0.00116	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—urinary bladder cancer	0.000261	0.00115	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—urinary bladder cancer	0.000259	0.00115	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—urinary bladder cancer	0.000252	0.00111	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000251	0.00111	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—urinary bladder cancer	0.000251	0.00111	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000242	0.00107	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00024	0.00106	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000232	0.00103	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—urinary bladder cancer	0.000232	0.00103	CcSEcCtD
Fingolimod—Asthenia—Methotrexate—urinary bladder cancer	0.000223	0.000986	CcSEcCtD
Fingolimod—Pruritus—Methotrexate—urinary bladder cancer	0.00022	0.000972	CcSEcCtD
Fingolimod—Diarrhoea—Methotrexate—urinary bladder cancer	0.000213	0.00094	CcSEcCtD
Fingolimod—Asthenia—Epirubicin—urinary bladder cancer	0.000209	0.000923	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—urinary bladder cancer	0.000206	0.00091	CcSEcCtD
Fingolimod—Dizziness—Methotrexate—urinary bladder cancer	0.000206	0.000909	CcSEcCtD
Fingolimod—Diarrhoea—Epirubicin—urinary bladder cancer	0.000199	0.00088	CcSEcCtD
Fingolimod—Headache—Methotrexate—urinary bladder cancer	0.000195	0.000861	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—urinary bladder cancer	0.000193	0.000854	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—urinary bladder cancer	0.000192	0.000851	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—urinary bladder cancer	0.000191	0.000842	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000184	0.000814	CcSEcCtD
Fingolimod—Headache—Epirubicin—urinary bladder cancer	0.000182	0.000806	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—urinary bladder cancer	0.000178	0.000787	CcSEcCtD
Fingolimod—Headache—Doxorubicin—urinary bladder cancer	0.000169	0.000746	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.00014	0.000319	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL2—urinary bladder cancer	0.000139	0.000317	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000139	0.000317	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—S100B—urinary bladder cancer	0.000139	0.000316	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000138	0.000314	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NCOR1—urinary bladder cancer	0.000138	0.000313	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NCOR1—urinary bladder cancer	0.000138	0.000313	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000136	0.00031	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—MTHFR—urinary bladder cancer	0.000136	0.00031	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL2—urinary bladder cancer	0.000134	0.000305	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL2—urinary bladder cancer	0.000134	0.000305	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—TYMS—urinary bladder cancer	0.000134	0.000304	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000132	0.000301	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—NCOR1—urinary bladder cancer	0.000132	0.000301	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GSTM1—urinary bladder cancer	0.000132	0.000301	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—RHOA—urinary bladder cancer	0.000132	0.0003	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PPARG—urinary bladder cancer	0.000128	0.000291	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000127	0.00029	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000127	0.00029	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL8—urinary bladder cancer	0.000127	0.00029	CbGpPWpGaD
Fingolimod—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000127	0.000289	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—GPX1—urinary bladder cancer	0.000127	0.000288	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL2—urinary bladder cancer	0.000127	0.000288	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TERT—urinary bladder cancer	0.000126	0.000287	CbGpPWpGaD
Fingolimod—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000125	0.000285	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000125	0.000284	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ERCC2—urinary bladder cancer	0.000124	0.000283	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—S100B—urinary bladder cancer	0.000123	0.00028	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—CREBBP—urinary bladder cancer	0.000123	0.000279	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL2—urinary bladder cancer	0.000122	0.000277	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL2—urinary bladder cancer	0.000122	0.000277	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL2—urinary bladder cancer	0.000122	0.000277	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TERT—urinary bladder cancer	0.000121	0.000276	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TERT—urinary bladder cancer	0.000121	0.000276	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000119	0.000271	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000118	0.000268	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—MTHFR—urinary bladder cancer	0.000117	0.000266	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL8—urinary bladder cancer	0.000116	0.000263	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—FGFR3—urinary bladder cancer	0.000116	0.000263	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ESR1—urinary bladder cancer	0.000112	0.000255	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FGFR3—urinary bladder cancer	0.000111	0.000253	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FGFR3—urinary bladder cancer	0.000111	0.000253	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NCOR1—urinary bladder cancer	0.000111	0.000252	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL2—urinary bladder cancer	0.000111	0.000251	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PPARG—urinary bladder cancer	0.00011	0.000251	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TERT—urinary bladder cancer	0.00011	0.000251	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ESR1—urinary bladder cancer	0.000108	0.000246	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ESR1—urinary bladder cancer	0.000108	0.000246	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—CREBBP—urinary bladder cancer	0.000106	0.000241	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—FGFR3—urinary bladder cancer	0.000101	0.00023	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTGS2—urinary bladder cancer	0.000101	0.000229	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CREBBP—urinary bladder cancer	9.85e-05	0.000224	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ESR1—urinary bladder cancer	9.82e-05	0.000223	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	9.81e-05	0.000223	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TERT—urinary bladder cancer	9.75e-05	0.000222	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IGF1—urinary bladder cancer	9.73e-05	0.000221	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—urinary bladder cancer	9.68e-05	0.00022	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.68e-05	0.00022	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.54e-05	0.000217	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PPARG—urinary bladder cancer	9.48e-05	0.000216	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CREBBP—urinary bladder cancer	9.48e-05	0.000216	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CREBBP—urinary bladder cancer	9.48e-05	0.000216	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IGF1—urinary bladder cancer	9.36e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1—urinary bladder cancer	9.36e-05	0.000213	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—urinary bladder cancer	9.32e-05	0.000212	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—urinary bladder cancer	9.32e-05	0.000212	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	9.25e-05	0.00021	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—urinary bladder cancer	9.14e-05	0.000208	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—CREBBP—urinary bladder cancer	9.11e-05	0.000207	CbGpPWpGaD
Fingolimod—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	9.02e-05	0.000205	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—FGFR3—urinary bladder cancer	8.95e-05	0.000203	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—RHOA—urinary bladder cancer	8.91e-05	0.000203	CbGpPWpGaD
Fingolimod—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.89e-05	0.000202	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—urinary bladder cancer	8.8e-05	0.0002	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—urinary bladder cancer	8.8e-05	0.0002	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—PTEN—urinary bladder cancer	8.77e-05	0.000199	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ESR1—urinary bladder cancer	8.69e-05	0.000198	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTGS2—urinary bladder cancer	8.68e-05	0.000197	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CREBBP—urinary bladder cancer	8.61e-05	0.000196	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—RHOA—urinary bladder cancer	8.58e-05	0.000195	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—RHOA—urinary bladder cancer	8.58e-05	0.000195	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1—urinary bladder cancer	8.5e-05	0.000193	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	8.47e-05	0.000193	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—urinary bladder cancer	8.46e-05	0.000192	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—EP300—urinary bladder cancer	8.37e-05	0.00019	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ERBB2—urinary bladder cancer	8.25e-05	0.000188	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NAT1—urinary bladder cancer	8.03e-05	0.000183	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	8.03e-05	0.000183	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—urinary bladder cancer	7.99e-05	0.000182	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ERBB2—urinary bladder cancer	7.94e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ERBB2—urinary bladder cancer	7.94e-05	0.000181	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL8—urinary bladder cancer	7.82e-05	0.000178	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—RHOA—urinary bladder cancer	7.79e-05	0.000177	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—urinary bladder cancer	7.77e-05	0.000177	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CREBBP—urinary bladder cancer	7.62e-05	0.000173	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PTEN—urinary bladder cancer	7.57e-05	0.000172	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL8—urinary bladder cancer	7.53e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL8—urinary bladder cancer	7.53e-05	0.000171	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1—urinary bladder cancer	7.52e-05	0.000171	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—urinary bladder cancer	7.48e-05	0.00017	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—urinary bladder cancer	7.48e-05	0.00017	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—urinary bladder cancer	7.47e-05	0.00017	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTGS2—urinary bladder cancer	7.46e-05	0.00017	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	7.34e-05	0.000167	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—urinary bladder cancer	7.29e-05	0.000166	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—EP300—urinary bladder cancer	7.22e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ERBB2—urinary bladder cancer	7.21e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—urinary bladder cancer	7.2e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—urinary bladder cancer	7.2e-05	0.000164	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MMP9—urinary bladder cancer	7.07e-05	0.000161	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CDKN1A—urinary bladder cancer	7.05e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PTEN—urinary bladder cancer	7.03e-05	0.00016	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—urinary bladder cancer	7.01e-05	0.000159	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—urinary bladder cancer	7.01e-05	0.000159	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—RHOA—urinary bladder cancer	6.89e-05	0.000157	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL8—urinary bladder cancer	6.84e-05	0.000155	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MMP9—urinary bladder cancer	6.81e-05	0.000155	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MMP9—urinary bladder cancer	6.81e-05	0.000155	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—urinary bladder cancer	6.79e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CDKN1A—urinary bladder cancer	6.79e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CDKN1A—urinary bladder cancer	6.79e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PTEN—urinary bladder cancer	6.77e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PTEN—urinary bladder cancer	6.77e-05	0.000154	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EP300—urinary bladder cancer	6.71e-05	0.000152	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	6.61e-05	0.00015	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—urinary bladder cancer	6.53e-05	0.000149	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SRC—urinary bladder cancer	6.52e-05	0.000148	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—PTEN—urinary bladder cancer	6.51e-05	0.000148	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EP300—urinary bladder cancer	6.46e-05	0.000147	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EP300—urinary bladder cancer	6.46e-05	0.000147	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.41e-05	0.000146	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ERBB2—urinary bladder cancer	6.38e-05	0.000145	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—urinary bladder cancer	6.37e-05	0.000145	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.33e-05	0.000144	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SRC—urinary bladder cancer	6.28e-05	0.000143	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SRC—urinary bladder cancer	6.28e-05	0.000143	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	6.24e-05	0.000142	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—EP300—urinary bladder cancer	6.21e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MMP9—urinary bladder cancer	6.18e-05	0.000141	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CDKN1A—urinary bladder cancer	6.16e-05	0.00014	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PTEN—urinary bladder cancer	6.15e-05	0.00014	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	6.08e-05	0.000138	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL8—urinary bladder cancer	6.05e-05	0.000138	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	6.01e-05	0.000137	CbGpPWpGaD
Fingolimod—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.89e-05	0.000134	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EP300—urinary bladder cancer	5.86e-05	0.000133	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—urinary bladder cancer	5.84e-05	0.000133	CbGpPWpGaD
Fingolimod—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.81e-05	0.000132	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—urinary bladder cancer	5.78e-05	0.000131	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—urinary bladder cancer	5.72e-05	0.00013	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SRC—urinary bladder cancer	5.7e-05	0.00013	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	5.7e-05	0.00013	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NAT1—urinary bladder cancer	5.7e-05	0.00013	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—urinary bladder cancer	5.64e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—urinary bladder cancer	5.63e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—urinary bladder cancer	5.63e-05	0.000128	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—urinary bladder cancer	5.5e-05	0.000125	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—urinary bladder cancer	5.5e-05	0.000125	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MMP9—urinary bladder cancer	5.47e-05	0.000124	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.45e-05	0.000124	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PTEN—urinary bladder cancer	5.44e-05	0.000124	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—urinary bladder cancer	5.4e-05	0.000123	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	5.21e-05	0.000118	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—urinary bladder cancer	5.2e-05	0.000118	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—urinary bladder cancer	5.2e-05	0.000118	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EP300—urinary bladder cancer	5.19e-05	0.000118	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—urinary bladder cancer	5.11e-05	0.000116	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SRC—urinary bladder cancer	5.05e-05	0.000115	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—urinary bladder cancer	5e-05	0.000114	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMP—urinary bladder cancer	4.86e-05	0.000111	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—urinary bladder cancer	4.8e-05	0.000109	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—urinary bladder cancer	4.72e-05	0.000107	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	4.69e-05	0.000107	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—urinary bladder cancer	4.62e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—urinary bladder cancer	4.62e-05	0.000105	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—urinary bladder cancer	4.59e-05	0.000104	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—urinary bladder cancer	4.52e-05	0.000103	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	4.43e-05	0.000101	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—urinary bladder cancer	4.42e-05	0.000101	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—urinary bladder cancer	4.42e-05	0.0001	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—urinary bladder cancer	4.42e-05	0.0001	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NAT2—urinary bladder cancer	4.4e-05	0.0001	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	4.32e-05	9.82e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—urinary bladder cancer	4.2e-05	9.54e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—urinary bladder cancer	4.18e-05	9.5e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—urinary bladder cancer	4.01e-05	9.12e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.93e-05	8.93e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RRM2—urinary bladder cancer	3.8e-05	8.63e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.72e-05	8.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.72e-05	8.47e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—urinary bladder cancer	3.71e-05	8.44e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—urinary bladder cancer	3.55e-05	8.07e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	3.52e-05	8e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO2—urinary bladder cancer	3.52e-05	8e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMP—urinary bladder cancer	3.45e-05	7.85e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	3.41e-05	7.75e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.41e-05	7.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.12e-05	7.1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.07e-05	6.97e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.9e-05	6.59e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NQO1—urinary bladder cancer	2.83e-05	6.44e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.82e-05	6.42e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.69e-05	6.13e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.5e-05	5.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.5e-05	5.67e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.42e-05	5.5e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	2.36e-05	5.38e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.26e-05	5.13e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.2e-05	5e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.17e-05	4.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.17e-05	4.94e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.08e-05	4.73e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.04e-05	4.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.04e-05	4.64e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.01e-05	4.57e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.92e-05	4.37e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.76e-05	4.01e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	3.81e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.63e-05	3.71e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.63e-05	3.71e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.58e-05	3.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.56e-05	3.55e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARG—urinary bladder cancer	1.56e-05	3.54e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.54e-05	3.51e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.54e-05	3.51e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.5e-05	3.4e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.48e-05	3.36e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.45e-05	3.3e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.36e-05	3.1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.32e-05	2.99e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.22e-05	2.78e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.1e-05	2.51e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.1e-05	2.49e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.07e-05	2.43e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	2.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.02e-05	2.32e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.02e-05	2.32e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.01e-05	2.29e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.01e-05	2.29e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.65e-06	2.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	9.48e-06	2.15e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.91e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	8.69e-06	1.98e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—urinary bladder cancer	7.58e-06	1.72e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—urinary bladder cancer	7.23e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARG—urinary bladder cancer	7.22e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.94e-06	1.58e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.68e-06	1.29e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.96e-06	1.13e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.73e-06	1.07e-05	CbGpPWpGaD
